Detalhe da pesquisa
1.
Targeting macrophages for enhancing CD47 blockade-elicited lymphoma clearance and overcoming tumor-induced immunosuppression.
Blood
; 139(22): 3290-3302, 2022 06 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-35134139
2.
Signaling lymphocytic activation molecule family receptors as potential immune therapeutic targets in solid tumors.
Front Immunol
; 15: 1297473, 2024.
Artigo
em Inglês
| MEDLINE | ID: mdl-38476238
3.
Effect of cabazitaxel on macrophages improves CD47-targeted immunotherapy for triple-negative breast cancer.
J Immunother Cancer
; 9(3)2021 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-33753567